20 October 2009 | World Forum | The Hague

Session 12 | Best practices

14.00 - 14.40 hrs
International Partnering
Dr. Cindy L. Bell
, Executive Vice President, Corporate Development, Genome Canada

From national to international consortia
in the Life Sciences
Prof.Dr. Thomas Hankemeier, Scientific Director, Netherlands Metabolomics Centre


Break 10 min.

14.50 - 15.30 hrs
OECD: The Bioeconomy to 2030:
Designing a Policy Agenda


Pierre-Alain Schieb, Counsellor and Head of Projects, OECD International Futures Programme


David Sawaya, Policy Analyst OECD International Futrres Programme


Bio-economy in the Netherlands
Roel Bol, Programme Director
Bio-based economy, Ministry Agriculture, Nature and
Food Quality

Life Sciences:
an international perspective
|
Biobased Economy: future prospects
|

 

International Partnering
Dr. Cindy L. Bell

Genome Canada - a not-for-profit organisation established in February 2000 - was given a mandate by the Government of Canada to develop and implement
a national strategy for supporting large-scale genomics and proteomics research projects,
for the benefit of all Canadians in key selected areas such as health, agriculture, environment, forestry, fisheries and new technology development.
As well, the organization is committed to assuming
a leadership role with regard to ethical, environmental, economic, legal and social (GE3LS) issues associated with genomics research, and to communicating with Canadians on these and other issues.

Genome Canada’s international strategy involves the engagement and assumption of leadership in select international research projects, workshops, consortia and partnerships. Genome Canada’s ongoing support and interest in several international consortium initiatives - the Structural Genomics Consortium,
the Public Population Project in Genomics, the International Knockout Mouse Consortium, and the Cancer Stem Cell Consortium - strengthens and enhances the international status of Canada and Canadian scientists.

 

From national to international consortia in
the Life Sciences

Prof.Dr. Thomas Hankemeier

The mission of the Netherlands Metabolomics Centre (NMC) is the creation of a world-class metabolomics knowledge infrastructure to improve personal health and quality of life. The NMC is a place of collaboration, where existing knowledge and expertise of NGI consortia, industry, research institutes, and individual research groups in the medical, plant science, and microbial fields combine in a joint common strategy for future technology development and application.
The NMC has now taken the initiative to explore the possibilities of an international metabolomics consortium to further strengthen their international collaborations.

 

OECD: The Bioeconomy to 2030: Designing a Policy Agenda
Pierre-Alain Schieb | David Sawaya

The OECD International Futures Project on
“The Bioeconomy to 2030: Designing a Policy Agenda”

The report is the outcome of an interdisciplinary foresight project by the OECD on the bioeconomy.
It provides a broad-based analysis of future developments in the three sectors where biotechnology has the greatest potential impact: agriculture, health and industry. It also explores the implications of developments in these sectors for the economy and society over the next two decades and develops a policy agenda.

 

Bio-economy in the Netherlands – a green industrial revolution
Roel Bol

 

 

pijl Back to Parallel Sessions